UBS initiated coverage on Eureka Forbes with a ‘Buy’ call, identifying it as a ‘steady earnings compounder’ with under-appreciated scale advantages in water purifiers and services. The brokerage set a target price of Rs 640, citing market growth driven by health awareness and expanding consumer base.
Positive Breakout: These 7 stocks cross above their 200 DMAs
In the Nifty500 pack, seven stocks’ closing prices crossed above their 200-day moving averages (DMA) on October 28, 2026, according to StockEdge’s technical scan data.